The Orphan Train Traveling Display exhibit at the Cherokee County Genealogy and History Library is reviving a generation’s ...

SAR446523, an investigational antibody targeting GPRC5D, received FDA orphan drug status and is in phase 1 trials for ...

Sanofi's SAR446523 gains FDA orphan drug status, offering hope for relapsed multiple myeloma patients with its targeted ...

Arcus Biosciences Inc. (NYSE:RCUS) is one of the biotech stocks to buy according to Wall Street analysts. On July 10, Arcus ...

Aileen Quinn, the original “Annie” from the 1982 film, visited Kansas City this week to support an inclusive production of ...

AbbVie said on Thursday its tariff exposure is not expected to exceed that of rivals, and raised its 2025 profit forecast ...

Q2 2025 Earnings Call Transcript July 30, 2025 Option Care Health, Inc. beats earnings expectations. Reported EPS is $0.41, ...

Kedrion Biopharma receives US FDA orphan drug designation for Coagadex to treat acquired Factor X deficiency: Fort Lee, New Jersey Thursday, July 31, 2025, 15:00 Hrs [IST] Kedrion ...

SHELTON, CT / ACCESS Newswire / July 30, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a clinical stage, leading global pioneer in the development of ...

Company expects to complete Phase 3 Aspire study in the second half of 2026. Aurora study of GTX-102 in additional ages and ...

Patient advocates called the OBBBA changes a “sweetheart deal to Big Pharma” and emphasized that these provisions forced ...

PILA PHARMA AB (publ) ("PILA PHARMA" or the "Company") announces that the last day of trading in paid subscribed units (Sw. BTU) in connection with the Company's rights issue of units which the Board ...